Showing results (121-130 of 466) with videos related to

Sort By:
Pageof 47
Pharmacology & Therapeutics|May 20, 2015
Pathogenesis and treatment of the cardiorenal syndrome: Implications of L-arginine-nitric oxide pathway impairmentNiwanthi W Rajapakse, Shane Nanayakkara, David M Kaye
Clinical Medicine Insights. Cardiology|January 19, 2018
Hospitalisation in Patients With Heart Failure With Preserved Ejection FractionShane Nanayakkara, Hitesh C Patel, David M Kaye
Current Hypertension Reports|May 10, 2020
The Emerging Role of Gut Dysbiosis in Cardio-metabolic Risk Factors for Heart FailureYusuke Sata, Francine Z Marques, David M Kaye
International Journal of Cardiology|May 19, 2015
Improvement in left ventricular ejection fraction and reverse remodeling in elderly heart failure patients on intense NT-proBNP-guided therapyBeat A Kaufmann, Kaatje Goetschalckx, Son Y Min, et al.
Journal of the American Heart Association|August 10, 2016
Prognostic Value of the Change in Heart Rate From the Supine to the Upright Position in Patients With Chronic Heart FailureMicha T Maeder, Marzena Zurek, Hans Rickli, et al.
Journal of Cardiac Failure|February 25, 2017
N-Terminal Pro-B-Type Natriuretic Peptide-Guided Therapy in Chronic Heart Failure Reduces Repeated Hospitalizations-Results From TIME-CHFNasser Davarzani, Sandra Sanders-van Wijk, Joël Karel, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|November 20, 2020
Intensification of pharmacological decongestion but not the actual daily loop diuretic dose predicts worse chronic heart failure outcome: insights from TIME-CHFJustas Simonavičius, Micha T Maeder, Casper G M J Eurlings, et al.
European Heart Journal|September 23, 2003
Chronic atrial fibrillation does not influence the magnitude of sympathetic overactivity in patients with heart failurePaul A Gould, Murray D Esler, David M Kaye
Pageof 47